Literature DB >> 359033

Lactoferrin content of peripheral blood cells.

R M Bennett, T Kokocinski.   

Abstract

The peripheral blood of 60 normal adults was separated into plasma, red cells, neutrophils, lymphocytes, monocytes and platelets. Lactoferrin concentrations were measured in the plasma and cell extracts and compared to those of lysozyme. The neutrophil lactoferrin content in males and post-menopausal females was found to be significantly higher than in pre-menopausal females. A small amount of lactoferrin was found in association with monocytes, but not with lymphocytes, erythrocytes and platelets. Neutrophil lysozyme concentrations did not exhibit any variation with sex and age; but the level in monocytes was higher than that in neutrophils. No correlation was observed between individual neutrophil lactoferrin values and the plasma level. Immunofluorescent studies showed neutrophils to have a lobulated pattern suggestive of nuclear staining. Monocytes did not show direct staining, but exhibited a peripheral pattern after prior exposure to lactoferrin--confirming the existence of a surface receptor. Gel chromatography indicated that neutrophil lactoferrin is in a polymerized or complexed form which elutes with the void volume on Sephadex G-200; serum lactoferrin consists of two forms, one of which also elutes with the void volume on Sephadex G-200.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 359033     DOI: 10.1111/j.1365-2141.1978.tb03620.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

1.  Differential staining of neutrophils and monocytes: surface and cytoplasmic iron-binding proteins.

Authors:  J C Barton; R T Parmley; T W Butler; S E Williamson; M B Lilly; R J Gualtieri; L W Heck
Journal:  Histochem J       Date:  1988-03

2.  Primary structure of glycans isolated from human leucocyte lactotransferrin. Absence of fucose residues questions the proposed mechanism of hyposideraemia.

Authors:  P Derisbourg; J M Wieruszeski; J Montreuil; G Spik
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

3.  Characterization of canine neutrophil granules.

Authors:  R T O'Donnell; B R Andersen
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation.

Authors:  T W Hutchens; J F Henry; T T Yip
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

5.  Lactoferrin targets T cells in the small intestine.

Authors:  Sanne Mie Nielsen; Gert H Hansen; E Michael Danielsen
Journal:  J Gastroenterol       Date:  2010-07-06       Impact factor: 7.527

Review 6.  Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment.

Authors:  G Vreugdenhil; A J Swaak
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

7.  Interleukin 1 administration in mice produces hypoferremia despite neutropenia.

Authors:  V R Gordeuk; P Prithviraj; T Dolinar; G M Brittenham
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

8.  Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses.

Authors:  Gonzalo de la Rosa; De Yang; Poonam Tewary; Atul Varadhachary; Joost J Oppenheim
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila.

Authors:  T F Byrd; M A Horwitz
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system.

Authors:  D R Ambruso; R B Johnston
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.